- Home
- PRTG
PRTG
Portage Biotech Inc.
as 04-01-2025 4:00pm EST
| Founded: | 1973 | Country: | British Virgin Islands |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -63.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.10 - $23.01 | Next Earning Date: | 04-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Portage Biotech Inc. News
PRTG Breaking Stock News: Dive into PRTG Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
Top Midday Gainers
MT Newswires
4 days ago
Top Premarket Gainers
MT Newswires
4 days ago
Update: Portage Biotech Shares Jump Premarket After 'Promising' Preclinical Results in Mesothelioma
MT Newswires
5 days ago
Portage Reports 'Promising' Preclinical Results in Mesothelioma
GlobeNewswire
5 days ago
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
GlobeNewswire
20 days ago
Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial
GlobeNewswire
2 months ago
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
GlobeNewswire
2 months ago
Portage Biotech Announces Completion of $2.15 Million Private Financing
Compare PRTG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRTG Portage Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.